for Epichlorohydrin from the weak Epoxy demand. Analysis of Cost and Expenses 1. In Q2 2019, Cost of sales was 3,696 MTHB, increased by 292 MTHB comparing to 2018 or 8.6% due to higher sales volume
all business sectors. Thai economy has been pressured from weak in tourism sector, consumption, and export sectors. However, Thailand continues easing country lockdown measures phase by phase since May
all business sectors. Thai economy has been pressured from weak in tourism sector, consumption, and export sectors. However, Thailand continues easing country lockdown measures phase by phase since May
of capital increase from the Initial Public Offering (IPO) in September,2017. Also, repay loans from financial institutions and no incurring interest expense in Q4/2017. Net Profits For the 1st quarter
income totaling Baht 47.79 million was mainly affected by the discontinue of profits from sale of investment assets which had occurred only in the year 2018. Nevertheless, Asia Medical & Agricultural
million or 438.9%. The most of transaction causing from the operational performance from subsidiary company which was fully operational in March 2019, and experiencing accumulated loss. Net Profits For the
baht. 92.65 percent because in the quarter 2 years 2016. The company profits from the sale to a third party the amount of 10.60 million baht. 4. Other income 3.35 million baht Decrease from the same
Initial Public Offering (IPO) in September,2017. Also, repay loans from financial institutions and no incurring interest expense in Q4/2017. Net Profits For the 2nd quarter of Year 2017 and 2018, the net
to small and medium-sized exporters, resulting clearer signs of acceleration in industrial production. In the meantime, private consumption only grew slowly due to weak overall household purchasing
Profit (Loss) of Associates and Joint Ventures • Share of profit from associates decreased 2.0% year-on-year from Baht 261 million in 2016 to Baht 256 million in 2017, primarily attributable to profits at